A Multi-Center and Randomized Control Trial of Cisplatin, Carboplatin, Oxaliplatin, Docetaxel and Gemcitabine Plus Surgery as Treatment for Relapsed and Refractory Non-Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 13 Mar 2018
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary) ; Gemcitabine (Primary) ; Oxaliplatin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms CCODG-NSCLC
- 08 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 08 Mar 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2019.
- 22 Sep 2016 New trial record